Pick how you
own a piece.
Four instruments, one conversation. From whole-ecosystem exposure to a single product handover — structured to match how much surface you want to hold.
Four ways in, one engine behind them
Ecosystem Share
flagshipA negotiated equity or revenue-share position across the DevProFlow portfolio — every live product, every in-build product, and future launches on the shared core.
Broadest exposure; benefits from every surface and every future product.
Per-Product Acquisition
asset salePurchase or license a single live product — codebase, domain, deployment and operating playbook transfer with it. Flagship candidates include MarktBit, NutriGo and PDF Studio.
Clean, fast close. Product keeps running on its current stack through handover.
Revenue Share
non-dilutiveA fixed percentage of a named product’s net revenue for a defined term — e.g. fund the growth of one subscription surface and share its MRR as it compounds.
Direct line between capital in and cash out; no governance complexity.
Staged Project Equity
milestone-tranchedEquity released in tranches against verified milestones — capital unlocks as the build proves out, tranche by tranche.
Risk is staged; each tranche maps to a delivered, checkable milestone.
Five steps to a signed term sheet
Deliberately un-spectacular: the same discipline we apply to product delivery applies to capital.
Intro call
Twenty minutes: which instrument fits, which products you want exposure to, amount range.
Mutual NDA
Standard two-way NDA covering the data room and any disclosed figures.
Data room
Verified revenue records, traffic analytics, infra cost baseline, registry and IP inventory, entity documents.
Term sheet
Instrument, amount, reporting cadence and exit/transfer terms — one page before legal.
Close & operate
Funds in, reporting starts. You get a standing view of the surfaces you backed.
Straight answers
What exactly do I own?
Depends on the instrument: equity in Lumina Labs (ecosystem share), a transferred product asset (per-product acquisition), a contractual revenue claim (revenue share), or milestone-tranched project equity. Each is written plainly in the term sheet.
How do I verify the products are real?
Before any call: eleven product links on the products page resolve to running platforms with published pricing. After NDA: checkout records, analytics and cost baselines in the data room.
Why share the ecosystem instead of selling one product?
Both are on the table — that is the point of the four instruments. Per-product sales recycle capital; an ecosystem share keeps us aligned on the whole portfolio compounding.
What reporting do partners get?
A monthly one-pager per instrument: revenue collected on your surfaces, product status changes, and the next milestone. Cadence and format are written into the term sheet.
Can I exit or transfer?
Transfer and buy-back mechanics are negotiated per instrument — revenue-share terms end naturally at term; equity transfers follow the SHA. Staged equity can renegotiate at each tranche gate.
Is this a securities offering?
No. This page describes private, negotiated arrangements between identified parties under NDA — not a public solicitation. Final terms are set in signed documents, not on this site.
Start the conversation
One email with the instrument and range you have in mind — we reply within one business day.